PCVX – vaxcyte, inc. (US:NASDAQ)
Stock Stats
News
Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs
1 Vanguard ETF That Could Soar 27.1% Before the End of 2024, According to a Top Wall Street Analyst [Yahoo! Finance]
We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely [Yahoo! Finance]
Vaxcyte, Inc. (NASDAQ: PCVX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Vaxcyte, Inc. (NASDAQ: PCVX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $140.00 price target on the stock.
Form SC 13G/A Vaxcyte, Inc. Filed by: FMR LLC
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Cowan Elvia
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Eydelman Mikhail
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: Wassil Jim
Form 4 Vaxcyte, Inc. For: Nov 07 Filed by: GUGGENHIME ANDREW
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.